By HHS – 30 Q&As – Report Review and Summary

Boston Children’s Hospital went from diagnosing almost no eleven-year-olds with central precocious puberty in 2017 through 2019 to diagnosing fifty in a single year. The Children’s Hospital of Philadelphia diagnosed nearly 250 minors with the same condition at age 10 or older between 2017 and 2024, including teenagers aged 14 to 18 — an age at which precocious puberty cannot exist by definition. These findings appear in Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine,” a 2026 report commissioned by the U.S. Department of Health and Human Services. The pattern documented is not scattered clinical error. It is the systematic misuse of two diagnostic codes — E34.9 (endocrine disorder, unspecified) and E30.1 (central precocious puberty) — to secure insurance reimbursement for puberty blockers and cross-sex hormones that insurers would not have covered under the actual diagnosis. The report’s own nationwide claims analysis found nearly $50 million billed under the endocrine code and $11 million under the impossible precocious puberty code, for children in the wrong age bands, between 2015 and 2025.
DETAILED PDF FILE OF THIS ATROCITY ATTACHED TO POST
LINK TO POST: https://open.substack.com/pub/unbekoming/p/wolves-in-white-coats-how-doctors?r=1dbkwf&utm_medium=ios




































You must be logged in to post a comment.